Lu Z - Search Results

1

Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.

Hou G, Bai Y, Jia A, Ren Y, Wang Y, Lu J, Wang P, Zhang J, Lu Z. Hou G, et al. Among authors: lu j, lu z. Can J Physiol Pharmacol. 2020 Jul;98(7):449-458. doi: 10.1139/cjpp-2019-0477. Epub 2020 Feb 14. Can J Physiol Pharmacol. 2020. PMID: 32058824

2

Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin.

Hou G, Yang S, Zhou Y, Wang C, Zhao W, Lu Z. Hou G, et al. Among authors: lu z. J Immunol Res. 2014;2014:845763. doi: 10.1155/2014/845763. Epub 2014 Apr 10. J Immunol Res. 2014. PMID: 24818169 Free PMC article.

3

Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Hou G, Lu Z, Liu M, Liu H, Xue L. Hou G, et al. Among authors: lu z. Dig Dis Sci. 2011 May;56(5):1315-22. doi: 10.1007/s10620-010-1474-0. Epub 2010 Nov 30. Dig Dis Sci. 2011. PMID: 21116717

4

[Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K].

Liu M, Lu Z, Zheng Y, Cui Y, Wang J, Hou G. Liu M, et al. Among authors: lu z. Zhonghua Zhong Liu Za Zhi. 2015 Dec;37(12):885-9. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26887615 Chinese.

5

Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.

Lu Z, Peng K, Wang N, Liu HM, Hou G. Lu Z, et al. J Immunol Res. 2016;2016:7828916. doi: 10.1155/2016/7828916. Epub 2016 Aug 9. J Immunol Res. 2016. PMID: 27595116 Free PMC article.

6

OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.

Peng KZ, Ke Y, Zhao Q, Tian F, Liu HM, Hou G, Lu Z. Peng KZ, et al. Among authors: lu z. Biochem Pharmacol. 2017 Sep 15;140:16-27. doi: 10.1016/j.bcp.2017.05.013. Epub 2017 May 21. Biochem Pharmacol. 2017. PMID: 28539264

7

Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.

Hou G, Zhao Q, Zhang M, Fan T, Liu M, Shi X, Ren Y, Wang Y, Zhou J, Lu Z. Hou G, et al. Among authors: lu z. Biomed Pharmacother. 2018 Oct;106:1348-1356. doi: 10.1016/j.biopha.2018.07.075. Epub 2018 Jul 23. Biomed Pharmacother. 2018. PMID: 30119206

8

FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.

Lu Z, Ren Y, Zhang M, Fan T, Wang Y, Zhao Q, Liu HM, Zhao W, Hou G. Lu Z, et al. Biomed Pharmacother. 2018 Nov;107:1370-1376. doi: 10.1016/j.biopha.2018.08.140. Epub 2018 Aug 31. Biomed Pharmacother. 2018. PMID: 30257352

9

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma.

Hou G, Zhao Q, Zhang M, Wang P, Ye H, Wang Y, Ren Y, Zhang J, Lu Z. Hou G, et al. Among authors: lu z. Onco Targets Ther. 2019 Jul 2;12:5215-5225. doi: 10.2147/OTT.S207238. eCollection 2019. Onco Targets Ther. 2019. PMID: 31308693 Free PMC article.

10

RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma.

Lu Z, Shi X, Gong F, Li S, Wang Y, Ren Y, Zhang M, Yu B, Li Y, Zhao W, Zhang J, Hou G. Lu Z, et al. Acta Pharm Sin B. 2020 Jun;10(6):1004-1019. doi: 10.1016/j.apsb.2020.01.010. Epub 2020 Jan 26. Acta Pharm Sin B. 2020. PMID: 32642408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,538 results

Search Page

Filters